The effects of Botulinum neurotoxin A on the passive mechanical properties of skeletal muscle have not been researched but may have significant clinical effects in the treatment of neuromuscular disorders including spasticity. Single fiber and fiber bundle passive mechanical testing was performed on muscles treated with Botulinum neurotoxin A. Myosin heavy chain and titin composition of single fibers was determined by gel electrophoresis. Muscle collagen content was determined using a hydroxyproline assay. Botulinum neurotoxin treated single fiber passive elastic modulus, stiffness, and slack sarcomere length was reduced from the contralateral side. Single fiber myosin heavy chain composition shifted from faster to slower isoforms after tre...
Botulinum neurotoxin (BoNT) is commonly used to manage focal spasticity in stroke survivors. This st...
<div><p>The aim of the present study was to investigate long term effects of motor denervation by bo...
Background and Purpose Botulinum toxin type A (BoNT/A) injections into hyperactive muscles provide e...
Botulinum Neurotoxin A (BoNT-A) injections have been used for the treatment of muscle contractures a...
AbstractBackgroundBotulinum toxin type A manages spasticity disorders in neurological central diseas...
INTRODUCTION Spasticity is a symptom often found in neuromuscular diseases such as Cerebral Palsy (C...
The thesis objective was to validate theoretical knowledge on botulinum toxin effects on spastic mus...
Recent experiments involving muscle force measurements over a range of muscle lengths show that effe...
Botulinum toxin type-A (BTX-A) is widely used for spasticity management and mechanically aims at red...
Objective: We studied systemic effects of botulinum toxin (BTX) treatment on muscle fiber conduction...
Botulinum toxin is now widely used in the treatment of several hyperkinetic movement disorders. To e...
This study has brought an overview of botulinum toxin and its influence on the human muscles, especi...
Botulinum toxin is now widely used in the treatment of several hyperkinetic movement disorders. To e...
To objectively quantify stiffness and clinical changes in the upper limb of poststroke patients foll...
Botulinum neurotoxins (BoNTs) produce local chemo-denervation by cleaving soluble N-ethylmaleimide-s...
Botulinum neurotoxin (BoNT) is commonly used to manage focal spasticity in stroke survivors. This st...
<div><p>The aim of the present study was to investigate long term effects of motor denervation by bo...
Background and Purpose Botulinum toxin type A (BoNT/A) injections into hyperactive muscles provide e...
Botulinum Neurotoxin A (BoNT-A) injections have been used for the treatment of muscle contractures a...
AbstractBackgroundBotulinum toxin type A manages spasticity disorders in neurological central diseas...
INTRODUCTION Spasticity is a symptom often found in neuromuscular diseases such as Cerebral Palsy (C...
The thesis objective was to validate theoretical knowledge on botulinum toxin effects on spastic mus...
Recent experiments involving muscle force measurements over a range of muscle lengths show that effe...
Botulinum toxin type-A (BTX-A) is widely used for spasticity management and mechanically aims at red...
Objective: We studied systemic effects of botulinum toxin (BTX) treatment on muscle fiber conduction...
Botulinum toxin is now widely used in the treatment of several hyperkinetic movement disorders. To e...
This study has brought an overview of botulinum toxin and its influence on the human muscles, especi...
Botulinum toxin is now widely used in the treatment of several hyperkinetic movement disorders. To e...
To objectively quantify stiffness and clinical changes in the upper limb of poststroke patients foll...
Botulinum neurotoxins (BoNTs) produce local chemo-denervation by cleaving soluble N-ethylmaleimide-s...
Botulinum neurotoxin (BoNT) is commonly used to manage focal spasticity in stroke survivors. This st...
<div><p>The aim of the present study was to investigate long term effects of motor denervation by bo...
Background and Purpose Botulinum toxin type A (BoNT/A) injections into hyperactive muscles provide e...